Intravenous (IV) Solutions Market Size Worth USD 17.9 Billion in 2032 | Baxter International Inc., Ajinomoto Co., Inc., B. Braun Group

The global Intravenous (IV) solution market is projected to experience substantial growth in the coming years, as per a recent market research report. Valued at USD 8.0 Billion in 2022, the market is expected to witness a robust revenue CAGR of 8.5% throughout the forecast period. Key factors propelling this growth include the increasing prevalence of chronic diseases, particularly cancer and neurological disorders, alongside technological advancements in therapy and patient safety measures.

Enhanced Patient Safety with Smart IV Pumps

One of the notable advancements in the IV solution market is the development of smart IV pumps. These pumps are designed to enhance patient safety by automatically adjusting infusion rates based on various factors such as patient weight, age, and medical condition. Such innovations aim to reduce the risk of medication errors and improve overall treatment outcomes.

Download Free Sample Report PDF @ https://www.emergenresearch.com/request-sample/2719

Integration of New Technologies

Emerging technologies like nanoparticle-based IV solutions, closed-loop systems, smart IV bags, and wireless IV pumps are revolutionizing the landscape of IV therapy. These innovations enable more targeted and personalized treatments, promising improved efficacy and patient comfort.

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, including cancer and neurological disorders, is a significant driver of market growth. Cancer remains a leading cause of death worldwide, with millions of new cases reported annually. Similarly, neurological disorders contribute to a significant number of global fatalities each year. The aging population and unhealthy lifestyles further contribute to the prevalence of these chronic conditions, necessitating the use of IV therapy for treatment and management.

Shift towards Minimally Invasive Procedures and Home Infusion Services

Advancements in technology have facilitated the transition towards minimally invasive procedures, leading to a rise in outpatient care and home infusion services. Patients now have the option to receive IV treatment in the comfort of their homes, offering greater convenience and reduced disruption to their daily lives. This trend is expected to drive market growth by making IV therapy more accessible and patient-centric.

Market Restraints and Segment Insights

Despite the promising growth prospects, the high cost of therapy remains a key challenge, particularly in low- and middle-income countries. Additionally, while the total parenteral nutrition (TPN) segment dominates the market due to the increasing prevalence of conditions like ulcerative colitis, the peripheral parenteral nutrition (PPN) segment is also witnessing steady growth, fueled by advancements in minimally invasive procedures and outpatient care.

IV Solution Top Companies and Competitive Landscape

The global IV solution market is fairly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing a more effective IV solution products.

Get Detailed Market Segmentation: https://www.emergenresearch.com/industry-report/intravenous-solution-market

Some major players included in the global IV solution market report are:
• Baxter International Inc.
• Ajinomoto Co., Inc.
• Braun Group
• Pfizer
• Grifols
• FRESENIUS KABI
• CSL Vifor
• ICU Medical
• Terumo Medical Corporation
• Otsuka

IV Solution Latest Industry Updates

• On 5 December 2022, Liquidia Corporation announced its partnership with Sandoz and Mainbridge Health to develop a new subcutaneous pump for administering Treprostinil Injection, a generic form of Remodulin. Treprostinil Injection is the first and only fully substitutable generic Treprostinil for parenteral administration. This generic form is offered to patients and physicians with the same level of service and support, but at a lower price than the branded drug.

• On 4 May 2022, Fresenius Kabi announced to acquire Ivenix, Inc. to expand its infusion therapy offerings in the U.S. Ivenix's cutting-edge infusion therapy platform complements Fresenius Kabi's existing portfolio, providing advanced hospital connectivity and interoperability solutions. This strategic move strengthens Fresenius Kabi's position in the infusion therapy market, offering a wider range of premium products to healthcare providers. The combination of Ivenix's hardware and software expertise with Fresenius Kabi's IV fluids and infusion devices creates a comprehensive and leading solution in the industry

IV Solution Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global IV solution market on the basis of type, application, end-use, and region:

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Total Parenteral Nutrition
o Peripheral Parenteral Nutrition

• Nutrition Outlook (Revenue, USD Billion; 2019-2032)
o Amino Acid Solution
o Vitamin and Minerals
o Carbohydrates
o Others

• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospitals
o Clinics
o Homecare

Request A Customization- https://www.emergenresearch.com/request-for-customization/2719

The global IV solution market is poised for rapid expansion, fueled by technological advancements, rising chronic diseases, and shifting healthcare preferences towards patient-centric care. As the demand for safer and more effective treatments continues to grow, stakeholders across the healthcare industry are expected to capitalize on emerging opportunities in this dynamic market landscape.

• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
3. Mexico
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Rest of Europe
o Asia Pacific
1. China
2. India
3. Japan
4. South Korea
5. Rest of APAC
o Latin America
1. Brazil
2. Rest of LATAM
o Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Turkey
5. Rest of Middle East & Africa

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.